Both countries have made similar announcements this year to favor more humane, and human-relevant methods for testing therapies, but the UK seems to lay out more specific plans and timelines.
As some countries move to deregulate regenerative medicine, others are looking to batten the hatches. Where the USA fits on that spectrum is anybody's guess right now.
